Abstract
Purpose
To evaluate the patency and clinical efficacy of percutaneous intraductal microwave ablation (PIMWA) and uncovered self-expandable metallic stents (USEMs) in inoperable malignant extrahepatic biliary obstruction.
Materials and methods
The procedures to be performed on patients with malignant inoperable extrahepatic biliary obstruction were decided by a multidisciplinary team including an interventional radiologist. In our study, 141 patients were evaluated retrospectively. Twenty-one patients who underwent PIMWA + USEMs with the MedWaves AveCure microwave system (AveCure® Intelligent Controller and Super-Flex Smart Catheter) and met the inclusion criteria were included in the study. Complications related to the intervention, stent patency, survival time, serum bilirubin levels, and the general condition of the patients were noted.
Results
The median stent patency and the median survival time were 108 and 143 days, respectively. The rates of 30-day, 2-month, 6-month and 8-month survival were 95.2%, 85.7%, 38.1%, and 14.3%, respectively.
Conclusion
The PIMWA + USEMs procedure is a safe, effective, and minimally invasive alternative palliative treatment method in patients with malignant inoperable extrahepatic biliary obstruction.
Similar content being viewed by others
References
Wu TT, Li WM, Li HC, Ao GK, Zheng F, Lin H. Percutaneous intraductal radiofrequency ablation for extrahepatic distal cholangiocarcinoma: a method for prolonging stent patency and achieving better functional status and quality of life. Card Vasc Int Radiol. 2017;40:260–9.
Sofi AA, Khan MA, Das A, Sachdev M, Khuder S, Nawras A, et al. Radiofrequency ablation combined with biliary stent placement versus stent placement alone for malignant biliary strictures: a systematic review and meta-analysis. Gastroint Endosc. 2018;87(944–951):e1.
Nennstiel S, Tschurtschenthaler I, Neu B, Algül H, Bajbouj M, Schmid RM, et al. Management of occluded self-expanding biliary metal stents in malignant biliary disease. Hepatobil Pancreat Dis Int. 2018;17:49–54.
Sawas T, Halabi SA, Parsi MA, Vargo JJ. Self-expandable metal stents versus plastic stents for malignant biliary obstruction: a meta-analysis. Gastrointest Endosc. 2015;82(2):256–67.
Boulay BR, Birg A. Malignant biliary obstruction: from palliation to treatment. World J Gastroint Oncol. 2016;8:498.
Ridtitid W. Management of an occluded biliary metallic stent. World J Gastrointest Endosc. 2012;4:157.
Li J, Li T, Sun P, Yu Q, Wang K, Chang W, et al. Covered versus uncovered self-expandable metal stents for managing malignant distal biliary obstruction: a meta-Analysis. PLoS ONE. 2016;11:1–16.
Mantero S, Longo I, Fiore GB, Severini A. Hyperthermia in the treatment of cholangiocarcinoma: development and testing of an endobiliary microwave device. Cardio Vasc Int Radiol. 2003;26:379–85.
Chu KF, Dupuy DE. Thermal ablation of tumours: biological mechanisms and advances in therapy. Nat Rev Cancer. 2014;14:199–208.
Liu D, Brace CL. Numerical simulation of microwave ablation incorporating tissue contraction based on thermal dose. Phys Med Biol. 2017;62(6):2070–86.
Poulou LS, Botsa E, Thanou I, Ziakas PD, Thanos L. Percutaneous microwave ablation vs radiofrequency ablation in the treatment of hepatocellular carcinoma. World J Hepatol. 2015;7:1054–63.
Glassberg MB, Ghosh S, Clymer JW, Qadeer RA, Ferko NC, Sadeghirad B, et al. Microwave ablation compared with radiofrequency ablation for treatment of hepatocellular carcinoma and liver metastases: a systematic review and metaanalysis. OncoTargets Ther. 2019;12:6407–38.
Uyanık SA, Öğüşlü U, Yılmaz B, Çevik H, Atlı E, Gümüş B. Percutaneous intraductal microwave ablation of malignant biliary strictures: initial experience. Am J Roentgenol. 2020;215(3):753–59.
Garcarek J, Kurcz J, Guzinski M, Janczak D, Sasiadek M. Ten years single center experience in percutaneous transhepatic decompression of biliary tree in patients. Adv Clin Exp Med. 2012;21:621–32.
Wu TT, Li HC, Li WM, Ao GK, Lin H, Zheng F, et al. Percutaneous intraluminal radiofrequency ablation for malignant extrahepatic biliary obstruction: a safe and feasible method. Dig Dis Sci. 2015;60:2158–63.
Filippiadis DK, Binkert C, Pellerin O, Hoffmann RT, Krajina A, Pereira PL. Cirse quality assurance document and standards for classification of complications: the cirse classification system. Card Vasc Int Radiol. 2017;40:1141–6.
Straten DV, Mashayekhi V, de Bruijn HS, Oliveira S, Robinson DJ. Oncologic photodynamic therapy: basic principles, current clinical status and future directions. Cancers. 2017;9:1–54.
Pereira SP, Jitlal M, Duggan M, Lawrie E, Beare S, O’Donoghue P, et al. PHOTOSTENT-02: Porfimer sodium photodynamic therapy plus stenting versus stenting alone in patients with locally advanced or metastatic biliary tract cancer. ESMO Open. 2018;3(5):e000379.
Skowronek J, Zwierzchowski G. Brachytherapy in the treatment of bile duct cancer—a tough challenge. J Contemp Brachyther. 2017;9:187–95.
Skowronek J. Current status of brachytherapy in cancer treatment—short overview. J Contemp Brachyther. 2017;9:581–9.
Carrafiello G, Laganà D, Mangini M, Fontana F, Dionigi G, Boni L, et al. Microwave tumors ablation: principles, clinical applications and review of preliminary experiences. Int J Surg. 2008;6:65–9.
Wang J, Zhao L, Zhou C, Gao K, Huang Q, Wei B, et al. Percutaneous intraductal radiofrequency ablation combined with biliary stent placement for nonresectable malignant biliary obstruction improves stent patency but not survival. Medicine (United States). 2016;95:1–6.
Inal M, Akgül E, Aksungur E, Seydaoǧlu G. Percutaneous placement of biliary metallic stents in patients with malignant hilar obstruction: unilobar versus bilobar drainage. J Vasc Int Radiol. 2003;14:1409–16.
Brountzos EN, Ptochis N, Panagiotou I, Malagari K, Tzavara C, Kelekis D. A survival analysis of patients with malignant biliary strictures treated by percutaneous metallic stenting. Card Vasc Int Radiol. 2007;30:66–73.
Karnabatidis D, Spiliopoulos S, Katsakiori P, Romanos O, Katsanos K, Siablis D. Percutaneous trans-hepatic bilateral biliary stenting in bismuth IV malignant obstruction. World J Hepatol. 2013;5:114–9.
Maybody M, Brown KT, Brody LA, Covey AM, Sofocleous CT, Thornton RH, et al. Primary patency of wallstents in malignant bile duct obstruction: single versus two or more noncoaxial stents. Card Vasc Int Radiol. 2009;32:707–13.
Lucatelli P, Corradini SG, Corona M, Corradini LG, Cirelli C, Saba L, et al. Risk factors for immediate and delayed-onset fever after percutaneous transhepatic biliary drainage. Card Vasc Int Radiol. 2016;39:746–55.
Liang H, Peng Z, Cao L, Qian S, Shao Z. Metal stenting with or without endobiliary radiofrequency ablation for unresectable extrahepatic cholangiocarcinoma. J Cancer Ther. 2015;06:981–92.
Hori Y, Naitoh I, Hayashi K, Kondo H. Covered duodenal self-expandable metal stents prolong biliary stent patency in double stenting: the largest series of bilioduodenal obstruction. J Gastroenterol Hepatol. 2018;33:696–703.
Flores-carmona DY, Alonso-lárraga JO, Hernández-guerrero A, Ramírez-solís ME. Comparison of covered and uncovered self-expandable stents in the treatment of malignant biliary obstruction. Revista Española De Enfermedades Digestivas. 2016;108:246–9.
Acknowledgements
We would like to thank Mehmet Serkan Gür MD and Volkan Çakır MD from our interventional radiology department for their expert advice and encouragement throughout the manuscript preparation.
Funding
This study was not supported by any funding.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical Approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For the study, approval from the ethics committee of our hospital with the 326 IRB number were obtained.
Informed Consent
Informed consent was obtained from all individual participants included in the study.
Consent for Publication
Consent for publication was obtained for every individual person’s data included in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Pekçevik, R., Ballı, Ö. Percutaneous Intraductal Microwave Ablation and Self-expandable Metallic Stenting: A New Treatment Method for Malignant Extrahepatic Biliary Obstruction. Cardiovasc Intervent Radiol 44, 110–117 (2021). https://doi.org/10.1007/s00270-020-02684-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00270-020-02684-2